Sanofi

Sanofi and Translate Bio Expand Collaboration

Sanofi Pasteur, the vaccines global business unit of French drugmaker Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, are formally expanding their existing 2018 collaboration and license agreement to develop mRNA vaccines for infectious diseases.

Sanofi to Build Vaccine plant near Lyon

Former GSK Vaccines Chief to Lead US Covid Sprint

Sanofi says US may Get Covid Vaccine first

Sanofi has urged the EU to create an equivalent of the US government’s Biomedical Advanced Research and Development Authority (BARDA) to coordinate research into a Covid-19 vaccine, or face being left behind.

Sanofi and Luminostics Pursue Smartphone COVID Test

Vaccine Research – an Ambitious and Important Venture

Flow Chemistry Opens up New Possibilities

Continuous Pharmaceutical Manufacturing

Sanofi and GSK Collaborate on COVID Vaccine

Technology and Innovation in the Pharmaceutical Industry

Trump’s Promotion of COVID Cure is Media Fodder

Sanofi and Translate Bio Link on COVID Vaccines

Azelis, Corteva and Sika to join Together for Sustainability Initiative

Sanofi to Establish new European API Producer

Sanofi Pasteur to Work with US on Coronavirus

Sanofi Downsizes Executive Board

Sanofi Completes $2.5 Billion Synthorx Acquistion

Sanofi to Buy Synthorx for $2.5 Billion

Sanofi Pays $315 Million to End Lemtrada Claims

Sanofi and Abbott in Diabetes Management Pact

Sustainable Chemical Supply Chains

Sanofi Buys Nonprescription Rights to Tamiflu

A Holistic System Approach

Unique Opportunity for Innovation and Improvement

A Visible Reference of Production-scale Micro Reaction Technology

A Technology on the Upswing

Benefits across Different Industries and Applications

Unsurpassed Heat and Mass Transfer Properties

Further Development Will Increase Confidence

A Boost to Efficiency, Adaptability and Responsiveness

Increased Process Performance and Safety

A Technology Whose Use is Indispensable

Flow Chemistry: Key Technology for Sustainable Processes

Sanofi’s Oral Sleeping Sickness Drug Approved

Sanofi Pays to Exit Regeneron Pact